Importantly, combinations are suggested to attenuate possible associated adverse side effects by decreasing therapy dosage, highly significant for pediatric patients.
← all excerpts
The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis.
1
—
—